Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.
Plus Receives $2M Series A for Cannabis-Infused Products
Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing. The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds.
Medical Marijuana, Inc. Announces Robert ’Bo’ Brannin as Senior Director of Operations for Subsidiary Kannaway
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that its subsidiary Kannaway® LLC is welcoming Robert "Bo" Brannin as its new Senior Director of Operations.
This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed investment advisor.
TheSeedInvestor.com 9375 E Shea Blvd Ste 100